Nonresponses and treatment failures with conventional empiric regimens in patients with community-acquired pneumonia

Infectious Disease Clinics of North America

Volumn 18, Issue 4, 2004, Pages 883-897

  Tan, James S ^a,b,c  

^a Section of Infectious Disease   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

^c Akron OH 44304 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; DALFOPRISTIN PLUS QUINUPRISTIN; KETOLIDE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHLAMYDIASIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE COURSE; HOSPITAL INFECTION; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; IMMUNE STATUS; INFECTION RATE; REVIEW; SMOKING; THORAX RADIOGRAPHY;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSTIC ERRORS; DRUG RESISTANCE, BACTERIAL; HUMANS; PNEUMONIA; RISK FACTORS; TREATMENT FAILURE;

EID: 8844271058     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2004.07.009     Document Type: Review

References (80)

1. M.S. Niederman, L.A. Mandell, and A. Anzueto Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention Am J Respir Crit Care Med 163 2001 1730 1754
2. L.A. Mandell, J.G. Bartlett, S.F. Dowell, T.M. File Jr., and D.M. Musher Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults Clin Infect Dis 37 2003 1405 1433
3. S.H. Feinsilver, A.M. Fein, M.S. Niederman, D.E. Schultz, and D.H. Faegenburg Utility of fiberoptic bronchoscopy in non-resolving pneumonia Chest 98 1990 1322 1326
4. R. Menéndez, M. Perpiñá, and A. Torres Evaluation of nonresolving and progressive pneumonia Semin Respir Infect 18 2003 103 111
5. D. Genne, L. Kaiser, T.N. Kinge, and D. Lew Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials Clin Microbiol Infect 9 2003 949 954
6. T.J. Marrie, H. Durant, and L. Yates Community-acquired pneumonia requiring hospitalization: 5 year prospective study Rev Infect Dis 11 1989 586 589
7. M. Ruiz, S. Ewig, and M.A. Marcos Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity Am J Respir Crit Care Med 160 1999 397 405
8. C. Malcolm, and T.J. Marrie Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting Arch Intern Med 163 2003 797 802
9. B. Fantin, J.P. Aubert, P. Unger, H. Lecoeur, and C. Carbon Clinical evaluation of the management of community-acquired pneumonia by general practitioners in France Chest 120 2001 185 192
10. M.F. Minogue, C.M. Coley, M.J. Fine, T.J. Marrie, W. Kapoor, and D.E. Singer Patients hospitalized after initial outpatient treatment for community-acquired pneumonia Ann Emerg Med 31 1998 376 380
11. B. Roson, J. Carratala, N. Fernandez-Sabe, F. Tubau, F. Manresa, and F. Gudiol Causes and factors associated with early failure in hospitalized patients with commmunity-acquired pneumonia Arch Intern Med 164 2004 502 508
12. T. Kuru, and J.P. Lynch 3rd Nonresolving or slowly resolving pneumonia Clin Chest Med 20 1999 623 651
13. A.A. El-Solh, A.T. Aquilina, H. Gunen, and F. Ramadan Radiographic resolution of community-acquired bacterial pneumonia in the elderly J Am Geriatr Soc 52 2004 224 229
14. M.J. Fine, M.A. Smith, C.A. Carson, S.S. Mutha, and S.S. Sankey Prognosis and outcome of patients with community-acquired pneumonia: a meta-analysis JAMA 275 1996 134 141
15. A.M. Neill, I.R. Martin, and R. Weir Community acquired pneumonia: aetiology and usefulness of severity criteria on admission Thorax 51 1996 1010 1016
16. A. Ortqvist, J. Hedlund, and L. Grillner Etiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization Eur Respir J 3 1990 1105 1113
17. G.D. Fang, M.J. Fine, and J. Orloff New and emerging etiologies for community-acquired penumonia with implications for therapy: a prospective multicenter study of 359 cases Medicine (Baltimore) 69 1990 307 316
18. British Thoracic Society Community-acuired pneumonia in adults in British hospitals in 1982-1983; a survey of aetiology, mortality, prognostic factors and outcome Q J Med 239 1987 195 220
19. M.S. Niederman, J.B. Bass Jr., and G.D. Campbell Guidelines for the initial management of adults with community-acquired pneumonia Am Rev Respir Dis 148 1993 1418
20. F. Arancibia, S. Ewig, and J.A. Martinez Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications Am J Respir Crit Care Med 162 2000 154 160
21. P. Davey, D. Rutherford, B. Graham, B. Lynch, and M. Malek Repeat consultations after antibiotic prescribing for respiratory infection: a study in one general practice Br J Gen Pract 44 1994 509 513
22. J.T. MacFarlane, A. Colville, A. Guidon, R.M. Macfarlane, and D.H. Rose Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community Lancet 341 1993 511 514
23. M.J. Fine, L.J. Hough, and A.R. Medsger The hospital admission decision for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study Arch Intern Med 157 1997 36 44
24. G. Waterer, G. Somes, and R. Wunderink Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia Arch Intern Med 16 2001 1837 1842
25. V.L. Yu, C.C.C. Chiou, and C. Feldman An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome Clin Infect Dis 37 2003 230 237
26. E.M. Mortensen, C.M. Coley, and D.E. Singer Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Outcome Research Team Cohort Study Arch Intern Med 162 2002 1059 1064
27. B.D. Kirby, K.M. Snyder, and R.D. Meyer Legionnaires' disease Medicine 59 1980 188
28. O.C. Finnegan, S.J. Fowles, and R.J. White Radiographic appearance of mycoplasma pneumonia Thorax 36 1981 469
29. J.T. MacFarlane, A.C. Miller, and W.H. Roderick Smith Comparative radiographic features of community-acquired Legionnaires disease, pneumococcal pneumonia, Mycoplasma pneumonia, and psittacosis Thorax 39 1984 28
30. S.H. Kirtland, and R.H. Winterbauer Slowly resolving, chronic, and recurrent pneumonia Clin Chest Med 12 1991 303 318
31. A.M. Fein, and S.H. Feinsilver Clinical approaches to slowly resolving pneumonia Semin Respir Infect 8 1993 1 2
32. M.J. Tan, J.S. Tan, R.H. Hamor, T.M. File Jr., and R.F. Breiman The radiologic manifestations of Legionnaires' disease Chest 117 2000 398
33. R.L. Mittl Jr., R.J. Schwab, and J.S. Duchin Radiographic resolution of community-acquired pneumonia Am J Respir Crit Care Med 149 1994 630
34. S.J. Jay, W.G. Johnson, and A.K. Pierce The radiologic resolution of Streptococcus pneumoniae pneumonia N Engl J Med 293 1975 798
35. A. Ortqvist, M. Kalin, L. Leideborn, and B. Lundberg Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia Chest 97 1990 576 582
36. M. Lujan, M. Gallego, D. Fontanals, D. Mariscal, and J. Rello Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality Crit Care Med 32 2004 625 631
37. T.J. Marrie Bacteremic pneumococcal pneumonia: a continuously evolving disease J Infect 24 1992 247 255
38. A.A. El-Solh, P. Sikka, F. Ramadan, and J. Davies Etiology of severe pneumonia in the very elderly Am J Respir Crit Care Med 163 2001 645 651
39. J.F. Plouffe, R.F. Breiman, and R.R. Facklam Bacteremia with Streptococcus pneumoniae implications for therapy and prevention: Franklin County Pneumonia Study Group JAMA 275 1996 194 198
40. C. Watanakunakorn, and T.A. Bailey Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996: a detailed analysis of 108 cases Arch Intern Med 157 1997 1965 1971
41. G.C. Shito, S. Mannelli, and A. Pesce Trend in the activity of macrolide and beta-lactam antibiotics and resistance development: Alexander Project Group J Chemother 9 Suppl 3 1997 18 28
42. J.J. Ruhe, and R. Hasbun Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance Clin Infect Dis 36 2003 1132 1138
43. K. Anderson, J.S. Tan, T.M. File Jr., J.R. Dipersio, B.M. Willey, and D.E. Low Emergence of levofloxacin-resistant pneumococciu in immunocompromised adults after therapy for community-acquired pneumonia Clin Infect Dis 37 2003 376 381
44. P.L. Ho, W.S. Tse, and D.N. Tsang Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case control study Clin Infect Dis 32 2001 701 707
45. K.P. Klugman The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents for the treatment of commmunity-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis J Antimicrob Chemother 38 Suppl A 1996 133 140
46. K.P. Klugman Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections Eur Respir J Suppl 36 2002 3s 8s
47. J.P. Metlay, J. Hofmann, and M.S. Cetron Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia Clin Infect Dis 90 2000 520 528
48. J.F. Moroney, A.E. Fiore, and L.H. Harrison Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance Clin Infect Dis 33 2001 797 805
49. R. Pallares, J. Linares, and M. Vadillo Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia N Engl J Med 333 1995 474 480
50. R. Pallares, O. Capdevila, and J. Linares The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections Am J Med 113 2002 120 126
51. I.R. Friedland, and K.P. Klugman Antibiotic-resistant pneumococcal disease in South African children Am J Dis Child 146 1992 920 923
52. I.R. Friedland Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin susceptible pneumococcal disease Pediatr Infect Dis J 14 1995 885 890
53. J. Aspa, O. Rajas, and F. Rodriguez de Castro Drug-resistant pneumococcal pneumonia: clinical relevance and related factors Clin Infect Dis 38 2004 787 798
54. D.R. Feikin, A. Schuchat, and M. Kolzak Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance 1995-1997 Am J Public Health 90 2000 223 229
55. G.S. Turett, S. Blum, B.A. Fazal, J.E. Justman, and E.E. Telzak Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus sroprevalence Clin Infect Dis 29 1999 321 327
56. K.P. Klugman, and C. Feldman Streptococcus pneumoniae respiratory tract infections Curr Opin Infect Dis 14 2001 173 179
57. P.R. Hsueh, L.J. Teng, L.N. Lee, P.C. Yang, S.W. Ho, and K.T. Luh Extremely high incidence of macrolide and trimethoprim-sufamethoxazole resistance among clinical isolates of Streptotoccus pneumoniae in Tawian J Clin Microbiol 37 1999 897 901
58. R.A. Reinert, A. Al-Lahham, and M. Lemperle Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany J Antimicrob Chemother 49 2002 61 68
59. T.B. Hyde, K. Gay, and D.S. Stephens Macrolide resistance among invasive Streptococcus pneumoniae isolates JAMA 286 2001 1857 1862
60. E. Perez-Trallero, C. Fernandez-Mazarrasa, and C. Garcia-Rey Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their eoclogical relationships: results of a 1 year (1998-1999) multicenter surveillance study in Spain Antimicrob Agents Chemother 45 2001 3334 3340
61. G.V. Doern, K.P. Heilmann, H.K. Huynh, P.R. Rhomberg, S.L. Coffman, and A.B. Brueggemann Antimicrobial resistance clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995 Antimicrob Agents Chemother 45 2001 1721 1729
62. T.M. File Jr., and J.S. Tan International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides Drugs 63 2003 181 205
63. S. Ewig, M. Ruiz, and A. Torres Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae Am J Respir Crit Care Med 159 1999 1835 1842
64. E. Nuermberger, and W.R. Bishai The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative Clin Infect Dis 38 2004 99 103
65. J.P. Lynch III, and F.J. Martinez Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia Clin Infect Dis 34 Suppl 1 2002 S27 S46
66. C.M. Fogarty, R.N. Greenberg, and L. Dunabar Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials Clin Ther 23 2001 425 439
67. C. Fogarty, R. Goldschmidt, and K. Bush Bacteremic pneumonia due multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin Clin Infect Dis 31 2000 613 615
68. K.A. Rodvold, M.H. Gotfried, and L.H. Danziger Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers Antimicrob Agents Chemother 41 1997 1399 1402
69. E. Pérez-Trallero, J.M. Marimon, L. Iglesias, and J. Larruskain Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug resistant isolates Emerg Infect Dis 9 2003 0810
70. A.L. Barry, P.C. Fuchs, and S.D. Brown Antipneuococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin) Antimicrob Agents Chemother 42 1998 945 946
71. R. Davidson, R. Cavalcanti, and J.L. Brunton Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia N Engl J Med 346 2002 747 750
72. M.B. Kays, D.W. Smith, M.E. Wack, and G.A. Denys Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia Pharmacotherapy 22 2002 395 399
73. D.K. Chen, A. McGeer, J.C. Azavedo, and D.E. Low Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canada surveillance network N Engl J Med 341 1999 233 239
74. J. Linares, A.G. De La Campa, and R. Pallares Fluoroquinolone resistance in Streptococcus pneumoniae N Engl J Med 341 1999 1546 1547
75. P.E. Empey, H.R. Jennings, A.C. Thornton, R.P. Rapp, and M.E. Evans Levofloxacin failure in a patient with pneumococcal pneumonia Ann Pharmacother 35 2001 687 690
76. A.G. De La Campa, M.J. Ferrandiz, F. Tubau, R. Pallares, F. Manresa, and J. Linares Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis Antimicrob Agents Chemother 47 2003 1419 1422
77. A. von Gottberg, H. Ludewicki, S. Bamber, C. Govind, A.W. Sturm, and K.P. Klungman Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in a South African child in a tuberculosis treatment center Pediatr Infect Dis J 22 2003 1020 1021
78. J.W. Alves dos Santos, A. Torres, and G.T. Michel Non-infectious and unusual infectious mimics of community-acquired pneumonia Respir Med 98 2004 488 494
79. A.A. El-Solh, A.T. Aquilina, R.S. Dhillon, F. Ramadan, P. Nowak, and J. Davies Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia Am J Respir Crit Care Med 166 2002 1038 1043
80. L. Rome, G. Murali, and M. Lippmann Nonresolving pneumonia and mimics of pneumonia Med Clin North Am 85 2001 1511 1530